UCB - Passività Correnti





Passività Correnti Cambiamento Data
Alcon AG USD 3B 45M 2026-03
Almirall EUR 350.64M 52.12M 2025-12
Amarin USD 179.64M 14.82M 2026-03
argenx SE USD 1.32B 278.28M 2025-12
AstraZeneca USD 32.57B 1.95B 2026-03
Bayer EUR 33.46B 875M 2026-03
Genmab DKK 1.43B 686M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
GRIFOLS EUR 2.12B 105M 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lakefront Biotherapeutics EUR 100.42M 52.44M 2026-03
Lonza CHF 3.57B 421M 2025-12
Merck EUR 9.35B 307M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Orion EUR 798.6M 238.3M 2026-03
Recordati EUR 1.37B 315.51M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
UCB EUR 4.4B 470M 2025-12
Unibail Rodamco EUR 3.13B 2.32B 2025-12